• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管上皮、巴雷特食管、发育异常和腺癌中的Toll样受体1、2、4和6

Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma.

作者信息

Huhta Heikki, Helminen Olli, Lehenkari Petri P, Saarnio Juha, Karttunen Tuomo J, Kauppila Joonas H

机构信息

Department of Pathology, University of Oulu, 90014 Oulu, Finland.

Department of Surgery, University of Oulu, 90014 Oulu, Finland.

出版信息

Oncotarget. 2016 Apr 26;7(17):23658-67. doi: 10.18632/oncotarget.8151.

DOI:10.18632/oncotarget.8151
PMID:27008696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5029654/
Abstract

BACKGROUND

Toll-like receptors (TLRs) recognize microbial and endogenous ligands and have already shown to play a role in esophageal cancer. In this study, we evaluated especially TLRs that sense bacterial cell wall components in Barrett's esophagus, dysplasia and esophageal adenocarcinoma.

METHODS

TLRs 1, 2, 4 and 6 were stained immunohistochemically and assessed in esophageal specimens from patients with esophageal dysplasia (n = 30) or adenocarcinoma (n = 99). Structures and lesions were evaluated including normal esophagus (n = 88), gastric (n = 67) or intestinal metaplasia (n = 51) without dysplasia, and low-grade (n = 42) or high-grade dysplasia (n = 37), and esophageal adenocarcinoma (n = 99).

RESULTS

We found TLR1, TLR2, TLR4 and TLR6 expression in all lesions. TLR expression increased in Barrett's mucosa and dysplasia. There was profound increase of TLR expression from gastric- to intestinal-type columnar epithelium. In cancers, high nuclear and cytoplasmic staining of TLR4 associated with metastatic disease and poor prognosis.

CONCLUSIONS

TLR1, TLR2, TLR4 and TLR6 are upregulated during malignant changes of esophageal columnar epithelium. Increased TLR4 expression associates with advanced stage and poor prognosis in esophageal adenocarcinoma.

摘要

背景

Toll样受体(TLRs)可识别微生物和内源性配体,且已证实在食管癌中发挥作用。在本研究中,我们特别评估了在巴雷特食管、发育异常和食管腺癌中感知细菌细胞壁成分的TLRs。

方法

对TLR1、TLR2、TLR4和TLR6进行免疫组织化学染色,并在食管发育异常患者(n = 30)或腺癌患者(n = 99)的食管标本中进行评估。评估的结构和病变包括正常食管(n = 88)、无发育异常的胃化生(n = 67)或肠化生(n = 51),以及低级别(n = 42)或高级别发育异常(n = 37)和食管腺癌(n = 99)。

结果

我们在所有病变中均发现了TLR1、TLR2、TLR4和TLR6。TLR表达在巴雷特黏膜和发育异常中增加。从胃型到肠型柱状上皮,TLR表达显著增加。在癌症中,TLR4的高核染色和胞质染色与转移性疾病及不良预后相关。

结论

在食管柱状上皮的恶性变化过程中,TLR1、TLR2、TLR4和TLR6上调。TLR4表达增加与食管腺癌的晚期阶段及不良预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9116/5029654/d83b32f39fd2/oncotarget-07-23658-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9116/5029654/8dfffeae3b45/oncotarget-07-23658-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9116/5029654/e1290304762c/oncotarget-07-23658-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9116/5029654/d83b32f39fd2/oncotarget-07-23658-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9116/5029654/8dfffeae3b45/oncotarget-07-23658-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9116/5029654/e1290304762c/oncotarget-07-23658-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9116/5029654/d83b32f39fd2/oncotarget-07-23658-g003.jpg

相似文献

1
Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma.食管上皮、巴雷特食管、发育异常和腺癌中的Toll样受体1、2、4和6
Oncotarget. 2016 Apr 26;7(17):23658-67. doi: 10.18632/oncotarget.8151.
2
Nuclear localization of Toll-like receptor 5 in Barrett's esophagus and esophageal adenocarcinoma is associated with metastatic behavior.Toll样受体5在巴雷特食管和食管腺癌中的核定位与转移行为相关。
Virchows Arch. 2016 Oct;469(4):465-70. doi: 10.1007/s00428-016-1989-7. Epub 2016 Jul 9.
3
Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.食管中炎症-化生-发育异常-腺癌序列中促炎细胞因子和核因子κB的表达
Am J Gastroenterol. 2005 Jun;100(6):1257-64. doi: 10.1111/j.1572-0241.2005.41338.x.
4
Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.Toll 样受体 2 信号转导与巴雷特食管中的溶酶体机制。
J Gastrointestin Liver Dis. 2016 Sep;25(3):273-82. doi: 10.15403/jgld.2014.1121.253.rc2.
5
Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.癌症干细胞标志物:CD133、CD44、Musashi-1和EpCAM在贲门黏膜-巴雷特食管-早期食管腺癌-进展期食管腺癌序列中的表达谱。
Pathol Res Pract. 2017 Mar;213(3):205-209. doi: 10.1016/j.prp.2016.12.018. Epub 2016 Dec 30.
6
High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.组织蛋白酶E在巴雷特食管和腺癌患者的组织而非血液中高表达。
Ann Surg Oncol. 2015 Jul;22(7):2431-8. doi: 10.1245/s10434-014-4155-y. Epub 2014 Oct 28.
7
Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.食管巴雷特食管、发育异常、腺癌序列中的黏蛋白表达谱。
Indian J Cancer. 2007 Jan-Mar;44(1):1-5. doi: 10.4103/0019-509x.31160.
8
Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett's esophagus, dysplasia and adenocarcinoma.食管上皮、巴雷特食管、发育异常及腺癌中的核酸感应Toll样受体3、7和8
Oncoimmunology. 2016 Jan 25;5(5):e1127495. doi: 10.1080/2162402X.2015.1127495. eCollection 2016 May.
9
Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases.胰岛素样生长因子II mRNA结合蛋白3(IMP3)作为诊断疑难病例食管腺癌新标志物的效用。
Turk J Gastroenterol. 2014 Jun;25(3):253-6. doi: 10.5152/tjg.2014.5454.
10
Time gated fluorescence spectroscopy in Barrett's oesophagus.巴雷特食管的时间分辨荧光光谱法。
Gut. 2003 Jan;52(1):28-33. doi: 10.1136/gut.52.1.28.

引用本文的文献

1
The oesophagus as an immune organ.作为免疫器官的食管。
Nat Rev Gastroenterol Hepatol. 2025 Jun 18. doi: 10.1038/s41575-025-01086-4.
2
The role of the esophageal and intestinal microbiome in gastroesophageal reflux disease: past, present, and future.食管和肠道微生物群在胃食管反流病中的作用:过去、现在与未来
Front Immunol. 2025 Feb 21;16:1558414. doi: 10.3389/fimmu.2025.1558414. eCollection 2025.
3
Mechanistic Insights on Microbiota-Mediated Development and Progression of Esophageal Cancer.微生物群介导的食管癌发生发展机制的见解

本文引用的文献

1
Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.Toll样受体4的下调通过ERK1/2信号通路对乙型肝炎病毒相关肝细胞癌产生抑制作用。
BMC Cancer. 2015 Oct 30;15:821. doi: 10.1186/s12885-015-1866-9.
2
Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.Toll样受体在人乳头瘤病毒阳性和阴性口咽鳞状细胞癌中的表达——一项体内和体外研究
Tumour Biol. 2015 Sep;36(10):7755-64. doi: 10.1007/s13277-015-3494-z. Epub 2015 May 5.
3
Toll-like receptor 9 expression in the natural history of Barrett mucosa.
Cancers (Basel). 2024 Sep 27;16(19):3305. doi: 10.3390/cancers16193305.
4
Biomarkers of lymph node metastasis in esophageal cancer.食管癌淋巴结转移的生物标志物。
Front Immunol. 2024 Sep 27;15:1457612. doi: 10.3389/fimmu.2024.1457612. eCollection 2024.
5
Clinical Significance of TNFSF14/LIGHT and CD160 in Gastric Cancer and Peptic Ulcer Dyspepsia.TNFSF14/LIGHT 和 CD160 在胃癌和消化性溃疡消化不良中的临床意义。
Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2669-2677. doi: 10.31557/APJCP.2024.25.8.2669.
6
Analysis of Fecal, Salivary, and Tissue Microbiome in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma.巴雷特食管、发育异常和食管腺癌患者粪便、唾液及组织微生物组分析
Gastro Hep Adv. 2022 Apr 9;1(5):755-766. doi: 10.1016/j.gastha.2022.04.003. eCollection 2022.
7
Toll-like receptors 1-9 in small bowel neuroendocrine tumors-Clinical significance and prognosis.小肠神经内分泌肿瘤中 Toll 样受体 1-9 的临床意义及预后。
PLoS One. 2024 May 6;19(5):e0302813. doi: 10.1371/journal.pone.0302813. eCollection 2024.
8
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. Toll 样受体导向的人类癌症治疗干预:分子和免疫学观点。
Front Immunol. 2023 Sep 26;14:1244345. doi: 10.3389/fimmu.2023.1244345. eCollection 2023.
9
Toll-like receptors 1, 2, 4, 5, and 6 in gastric cancer.胃癌中的 Toll 样受体 1、2、4、5 和 6。
Virchows Arch. 2024 Oct;485(4):655-664. doi: 10.1007/s00428-023-03635-1. Epub 2023 Sep 26.
10
High TLR6 Expression Status Predicts a More Favorable Prognosis after Esophagectomy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma.高 TLR6 表达状态预示着局部晚期胸段食管鳞癌患者行食管切除术预后更好。
Curr Oncol. 2023 May 4;30(5):4724-4735. doi: 10.3390/curroncol30050356.
Toll样受体9在Barrett黏膜自然病程中的表达
Virchows Arch. 2015 Jul;467(1):9-18. doi: 10.1007/s00428-015-1770-3. Epub 2015 Apr 3.
4
Acid suppressing therapy as a risk factor for Candida esophagitis.抑酸治疗作为念珠菌食管炎的一个风险因素。
Dis Esophagus. 2016 Jul;29(5):479-83. doi: 10.1111/dote.12354. Epub 2015 Apr 1.
5
Microbiome, innate immunity, and esophageal adenocarcinoma.微生物组、固有免疫与食管腺癌
Clin Lab Med. 2014 Dec;34(4):721-32. doi: 10.1016/j.cll.2014.08.001. Epub 2014 Sep 26.
6
Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis.Toll样受体4通过脂多糖刺激促进人乳腺癌细胞的侵袭性,且在有淋巴结转移的患者中过表达。
PLoS One. 2014 Oct 9;9(10):e109980. doi: 10.1371/journal.pone.0109980. eCollection 2014.
7
Low expression of nuclear Toll-like receptor 4 in laryngeal papillomas transforming into squamous cell carcinoma.喉乳头状瘤向鳞状细胞癌转变过程中核内Toll样受体4的低表达
Otolaryngol Head Neck Surg. 2014 Nov;151(5):785-90. doi: 10.1177/0194599814549730. Epub 2014 Sep 9.
8
Pattern-recognition receptors and gastric cancer.模式识别受体与胃癌。
Front Immunol. 2014 Jul 22;5:336. doi: 10.3389/fimmu.2014.00336. eCollection 2014.
9
Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo.抑制Toll样受体4可在体外和体内抑制人非小细胞肺癌癌细胞的生长及炎性细胞因子的分泌。
Int J Oncol. 2014 Aug;45(2):813-21. doi: 10.3892/ijo.2014.2479. Epub 2014 Jun 2.
10
Toll-like receptors in esophageal cancer.食管癌中的Toll样受体
Front Immunol. 2014 May 7;5:200. doi: 10.3389/fimmu.2014.00200. eCollection 2014.